0000950170-24-010943.txt : 20240202
0000950170-24-010943.hdr.sgml : 20240202
20240202205125
ACCESSION NUMBER: 0000950170-24-010943
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240202
DATE AS OF CHANGE: 20240202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gergen Mark J
CENTRAL INDEX KEY: 0001373110
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39376
FILM NUMBER: 24593665
MAIL ADDRESS:
STREET 1: C/O MIRATI THERAPEUTICS INC.
STREET 2: 9393 TOWN CENTRE DRIVE, STE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Poseida Therapeutics, Inc.
CENTRAL INDEX KEY: 0001661460
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472846548
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9390 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-779-3100
MAIL ADDRESS:
STREET 1: 9390 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
ownership.xml
4
X0508
4
2024-02-01
false
0001661460
Poseida Therapeutics, Inc.
PSTX
0001373110
Gergen Mark J
C/O POSEIDA THERAPEUTICS, INC.
9390 TOWNE CENTER DRIVE SUITE 200
SAN DIEGO
CA
92121
true
true
false
false
Executive Chairman
false
Common Stock
2024-02-01
4
F
false
47162
3.41
D
685448
D
Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2022.
/s/ Harry J.Leonhardt, Attorney-in-Fact
2024-02-02